Real-world experience and outcomes of hepatocellular carcinoma (HCC) treated with transarterial radioembolization (TARE)

被引：0
|
作者：
Das, Parthib
Min, Eric
Paul, Samuel
Manne, Ashish
机构：
[1] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA
[2] Ohio State Univ, Coll Med, Columbus, OH USA
[3] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.3_suppl.463
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：463 / 463
页数：1
相关论文
共 50 条
  • [1] Predictors of good outcomes in patients with hepatocellular carcinoma (HCC) treated with transarterial radioembolization (TARE)
    Das, Parthib
    Paul, Samuel
    Min, Eric
    Mittra, Arjun
    Malalur, Pannaga G.
    Manne, Ashish
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] MORTALITY IN PATIENTS TREATED WITH TRANSARTERIAL RADIOEMBOLIZATION (TARE) OR SBRT FOR HEPATOCELLULAR CARCINOMA (HCC)
    Chaudhary, Ammad J.
    Harris, Kevin B.
    Fahad, Hamna
    Cavataio, Joseph
    Shahzil, Muhammad
    Toiv, Avi
    Rehman, Sheema
    Suresh, Suraj
    Watson, Andrew
    Salgia, Reena
    GASTROENTEROLOGY, 2024, 166 (05) : S1737 - S1738
  • [3] A SYSTEMATIC REVIEW AND META-ANALYSIS OF TRANSARTERIAL RADIOEMBOLIZATION (TARE) FOR HEPATOCELLULAR CARCINOMA (HCC)
    Higgins, L.
    Rose, S.
    Lorenzetti, D.
    Sutherland, L.
    Burak, K. W.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S253 - S254
  • [4] Transarterial Radioembolization (TARE) in Hepatocellular Carcinoma (HCC) using 90Y Resin and Glass Microspheres
    Rotger Regi, A.
    Orcajo Rincon, J.
    Ardila Manjarrez, J.
    Perez Pascual, R.
    Mari Hualde, A.
    Henao Celada, Y.
    Matilla Pena, A.
    Mikel, E.
    Alonso Farto, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S581 - S581
  • [5] Real-world survival of patients (pts) with colorectal adenocarcinoma liver metastases (CRLM) treated with transarterial radioembolization (TARE).
    Mahmood, Sharmeen
    Hagopian, Garo Greg
    Sadeghi, Ben
    Kuo, Jeffrey V.
    Imagawa, David
    Fernando, Dayantha
    Abi-Jaoudeh, Nadine
    Dayyani, Farshid
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 40 - 40
  • [6] Real-world outcomes of patients with hepatocellular carcinoma treated with transarterial radioembolization: results from CIRT, a large European prospective observational study
    Kolligs, Frank
    Arnold, Dirk
    Helmberger, Thomas
    Maleux, Geert
    Peynircioglu, Bora
    Schaefer, Niklaus
    Golfieri, Rita
    Pfammatter, Thomas
    Ronot, Maxime
    de Jong, Niels
    Sangro, Bruno
    JOURNAL OF HEPATOLOGY, 2021, 75 : S244 - S245
  • [7] Real-world experience and outcomes of immune-checkpoint inhibitors (ICI) in hepatocellular carcinoma (HCC)
    Paul, Samuel
    Min, Eric
    Benson, Katherine K.
    Xu, Menglin
    Noonan, Anne M.
    Mittra, Arjun
    Malalur, Pannaga G.
    Roychowdhury, Sameek
    Jin, Ning
    Hays, John L.
    Elkhatib, Rifat T.
    Rahman, Shafia
    Miller, Eric David
    Pardo, Dayssy Alexandra Diaz
    Manne, Ashish
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Acute and chronic deterioration in liver function after transarterial radioembolization (TARE) in US patients (pts) with hepatocellular carcinoma (HCC)
    Miksad, Rebecca A.
    Piscaglia, Fabio
    Xia, Fang
    Fellous, Marc Mardoche
    Ogasawara, Sadahisa
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [9] A bibliometric analysis of 30 years of research on transarterial radioembolization (TARE) for hepatocellular carcinoma
    Hu, Tongyao
    Xu, Qifan
    Jia, Guorong
    Wang, Tao
    Zuo, Changjing
    FRONTIERS IN PHARMACOLOGY, 2025, 15
  • [10] Transradial Access for Transarterial Radioembolization (TARE) in Patients with Hepatocellular Carcinoma: Comparison with Transfemoral Access
    Abdullah Yakupoğlu
    Özden Sıla Ulus Buturak
    CardioVascular and Interventional Radiology, 2023, 46 : 1359 - 1364
12345